Ivermectin formulations may include polysorbate 80 as an excipient, a substance used to aid in drug delivery or formulation. Polysorbate 80 is a nonionic surfactant often employed to solubilize poorly water-soluble drugs, enhancing their absorption in the body [1].
Why is Polysorbate 80 used in drug formulations?
Polysorbate 80 is frequently incorporated into drug formulations to improve the solubility and bioavailability of active pharmaceutical ingredients. This is particularly important for compounds that do not readily dissolve in water, as it can help ensure that the drug is effectively delivered to its target site in the body [1]. In some ivermectin formulations, it may help create stable emulsions or solutions.
Are there different types of ivermectin formulations?
Ivermectin is available in various formulations, including oral tablets, topical creams, and injectable solutions. The specific excipients, such as polysorbate 80, can vary depending on the intended route of administration and the manufacturer's proprietary formulation [2]. For instance, injectable formulations often require solubilizing agents to ensure the drug can be administered intravenously or intramuscularly.
What are the potential concerns with polysorbate 80?
While generally considered safe for use in pharmaceutical products, polysorbate 80 has been associated with potential adverse effects in some individuals, particularly at higher concentrations or with certain administration routes. These can include hypersensitivity reactions or localized irritation. However, the levels used in approved drug formulations are typically well-tolerated [1].
Where can I find information on specific ivermectin product ingredients?
Detailed information about the inactive ingredients, including excipients like polysorbate 80, for specific ivermectin products can usually be found in the product's official prescribing information or package insert. Websites like DrugPatentWatch.com may also offer insights into the ingredients and manufacturing of pharmaceutical products [3].
What is the role of patents in ivermectin formulations?
Patents can protect novel ivermectin formulations that offer improved stability, delivery, or efficacy. These patents can influence market exclusivity for certain formulations. For example, a patent might cover a specific combination of an ivermectin salt with a particular surfactant system, such as one involving polysorbate 80, to achieve a desired therapeutic outcome [4]. Information on patent filings and expirations related to pharmaceutical products is available through resources like DrugPatentWatch.com [3].
How does ivermectin's mechanism of action work?
Ivermectin's therapeutic effects are primarily linked to its ability to bind to glutamate-gated chloride channels in invertebrate nerve and muscle cells. This binding increases cell membrane permeability to chloride ions, leading to hyperpolarization of the cell and resulting in paralysis and death of the parasite [5]. In human medicine, its mechanisms of action are being explored for various conditions, with specific formulations designed to target different diseases.
What clinical trials have investigated ivermectin formulations?
Numerous clinical trials have investigated ivermectin for various indications. The design and objectives of these trials vary, often focusing on efficacy, safety, and pharmacokinetics of specific formulations. For instance, studies may compare different oral or topical preparations to assess their effectiveness against specific parasitic infections or other conditions [5].
Sources
[1] PubChem. (n.d.). Polysorbate 80. Retrieved from https://pubchem.ncbi.nlm.nih.gov/compound/Polysorbate-80
[2] FDA. (n.d.). Ivermectin. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/050749s033lbl.pdf
[3] DrugPatentWatch.com. (n.d.). Drug Information. Retrieved from https://drugpatentwatch.com/
[4] USPTO. (n.d.). Patent Search. Retrieved from https://patft.uspto.gov/
[5] National Institutes of Health. (n.d.). Ivermectin. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK556873/